Ross Clark

Ross Clark

Ross Clark is a leader writer and columnist who has written for The Spectator for three decades. His books include Not Zero and The Road to Southend Pier.

Test and Trace was an expensive failure

Before we had vaccines, NHS Test and Trace was supposed to be the breakthrough that would return us to a normal life. After all, testing, tracing and isolating contacts of infected people was credited with keeping Covid infections down in South Korea, Taiwan and elsewhere, so why wouldn’t it work here?  Instead, we had a

Ross Clark

Will the economy really rebound after lockdown?

Bank of England chief economist Andy Haldane last week described the UK economy as a ‘coiled spring’ waiting to rebound just as soon as lockdown restrictions are eased. But is it a spring like the one on which Zebedee from the Magic Roundabout used to bounce around, or is it like a Slinky – the

Do school closures slow infections?

Will schools in England reopen on 8 March, and if so will it be partially or fully? It is likely to be the first firm measure to be announced when the Prime Minister presents his roadmap back to freedom next Monday. He has, after all, promised to give schools two weeks’ notice of when they will

Why are so many health workers turning down the vaccine?

On Saturday the government hit its target of administering a first vaccine dose to 15 million of the highest-risk groups for Covid 19. By now, everyone over the age of 70, all healthcare workers and vulnerable groups should have been offered a vaccine. It is an impressive achievement which stands in contrast to many of

Why aren’t we in a recession?

Well, that’s alright, then — we’re not going to have another recession. True, the Bank of England’s monetary policy committee expects the economy to shrink by 4 per cent in the first quarter of this year — following a fall of 9.9 per cent fall last year, itself the deepest plunge in economic growth in

Critics of the 10-year Covid jail sentence are right, but out of touch

Not for the first time, metropolitan-based commentators and MPs have proved themselves to be out of kilter with the wider population. But there is an especially interesting disparity over the government’s proposals for ten-year jail sentences for travellers who try to conceal they have travelled from one of 33 ‘red list’ countries in order to

Ross Clark

Covid is hastening the creep towards a cashless society

If your local pub ever reopens, don’t be surprised if one thing is missing: the till. The anti-cash lobby is seeking to take advantage of the pandemic to rid us of our banknotes once and for all. When UK Finance — the trade body for the banking and payments industry — pushed the government two

Ross Clark

The cashless lobby is cashing in on Covid-19

Coronavirus, we have been warned many times, has brought scammers out in force. But lobbyists are not far behind. Their activities may not be illegal, but they are pretty disgraceful nonetheless. Hardly had the coronavirus outbreak begun in January than my email inbox began to fill up with press releases claiming that the contagion was

How effective are the Covid vaccines?

Reports have filtered through this morning about Public Health England’s assessment of the efficacy of the two vaccines so far administered to the public. The results have not yet been published, but the efficacy rates quoted in the Sun suggest that the Pfizer vaccine has proved to be between 79 and 84 per cent effective at

Ross Clark

Green energy is a Dot-com bust waiting to happen

Scottish Widows is committed to net zero alright. For years, the endowment policy I had with it was worth pretty well just what I had paid into it. Although, on second thoughts, maybe Maria Nazarova-Doyle, head of pension investments at Scottish Widows, wasn’t referring to the returns on its policies when she said this week:

The class of Covid will pay the price for years to come

Schools in England, it seems, will reopen fully on 8 March at the earliest – a full two months after they closed. The Prime Minister has declined to bring this forward, in spite of new Covid cases falling at a rate of 25 per cent per week. The Scottish and Welsh governments have both said

Can we boost immunity with the vaccines we have now?

What to make of the news this morning that Oxford University is to ask for volunteers to take part in a trial to ‘mix and match’ the Pfizer and AstraZeneca vaccines? Researchers will ask for 820 volunteers, all over 50 years old, who will be given two shots of a vaccine, two weeks apart. Some

How alcohol deaths hit a record high during lockdown

Almost a year after the statistics were first published, the country remains horrified by the daily total of Covid 19-related deaths. Meanwhile, we are rather less apt to notice other statistics related to harm and death, which may be an unintended by-product of the fight against Covid-19.  The Office of National Statistics’ (ONS) latest figures for the

Ross Clark

Will Sturgeon admit to the cost of independence?

I’m not a great fan of economic modelling. Remember, for example, the Treasury’s infamous claim that unemployment would rise by between 500,000 and 800,000 within two years of a vote for Brexit (i.e. before we had actually left). In the event, unemployment fell in 2018 to reach the lowest level since the mid-1970s. Yet having

Ross Clark

The problem with taxing the self-employed

Last year, when Rishi Sunak, after some dithering, came up with a scheme to help the self-employed during the pandemic, he made clear that it would come with a quid pro ro: higher taxes for the self-employed in the longer run. With his second Budget coming up on 3 March will he take the initiative

New Oxford data supports UK vaccine strategy

Ever since the Oxford-AstraZeneca team announced the results of its Phase 3 trials last November, there has been a suspicion among some that their vaccine is the poor relation of the messenger RNA vaccines developed by Pfizer and Moderna. It might be cheap compared with the others, it might be easy to store and transport,

Ross Clark

Can ‘surge testing’ get new variants under control?

A year on, in one sense we’re pretty well back to where we started — with the government attempting to snuff out the South African variant of the SARS-CoV-2 virus in the same way as it did the original Wuhan version. It didn’t work then, and we rapidly moved to the second phase of the

One year after Brexit, Britain is reaping the benefits

A year ago today Britain awoke to a rather muted celebration – which seemed to consist largely of a bubble car driving around Parliament Square with a Union Jack in tow – ready to face up to a brave new future outside the EU. Who would have imagined then that the Observer would mark the

Could this drug offer immediate protection from Covid-19?

When Donald Trump returned to the White House after a brief spell in hospital with Covid-19 last October he made a video attributing his rapid recovery to a drug he called ‘Regeneron’. ‘They call it a therapeutic drug, but to me it wasn’t therapeutic – it made me better,’ he said. ‘I call that a

Ross Clark

The GameStop surge is just another Ponzi scheme

Who doesn’t wish they hadn’t tucked away a few GameStop shares at the beginning of this year? It’s not a great company – more a Blockbuster Video whose time has come and gone, another bricks and mortar retailer destroyed by a shift to online sales, in this case of video games. But what does that